Company Valuation: Biosynex

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 151.6 289.9 141 85.85 18.51 11.17
Change - 91.16% -51.35% -39.13% -78.44% -39.63%
Enterprise Value (EV) 1 130.6 193.2 105.9 125.7 71.44 64.36
Change - 47.93% -45.16% 18.6% -43.14% -9.91%
P/E 5.44x 2.63x 9.08x -2.42x -0.43x -0.19x
PBR 2.29x 1.62x 0.87x 0.72x 0.23x 0.3x
PEG - 0x -0.1x 0x -0x 0x
Capitalization / Revenue 0.99x 0.76x 0.72x 0.92x 0.18x 0.12x
EV / Revenue 0.85x 0.5x 0.54x 1.35x 0.71x 0.68x
EV / EBITDA 2.84x 1.36x 2.28x -4.21x -3.22x -4.72x
EV / EBIT 2.86x 1.37x 2.72x -3.48x -2.59x -2.47x
EV / FCF 7.61x 2.62x -3.59x -2.83x -43.6x 4.54x
FCF Yield 13.1% 38.1% -27.9% -35.3% -2.29% 22%
Dividend per Share 2 0.2 2 - - - -
Rate of return 1.2% 7.6% - - - -
EPS 2 3.05 10.01 1.52 -3.45 -4.03 -3.159
Distribution rate 6.56% 20% - - - -
Net sales 1 153.9 382.5 196.6 92.98 101.2 95.19
EBITDA 1 46.02 141.8 46.49 -29.82 -22.16 -13.64
EBIT 1 45.73 140.7 38.88 -36.15 -27.53 -26.05
Net income 1 31.37 104 15.66 -36.95 -43.33 -58.22
Net Debt 1 -21.07 -96.72 -35.09 39.8 52.94 53.19
Reference price 2 16.6000 26.3200 13.8000 8.3500 1.7200 0.5960
Nbr of stocks (in thousands) 9,135 11,014 10,220 10,281 10,761 18,748
Announcement Date 21/4/21 25/4/22 28/4/23 30/4/24 30/4/25 7/5/26
1EUR in Million2EUR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 19.51M
-51.98x16.6x-121.91x-.--% 21.74B
16.92x1.87x7.92x1.51% 9.36B
22.51x4.22x11.96x - 6.49B
-58.27x8.99x-76.56x-.--% 6B
20.58x7.08x15.99x2.8% 5.57B
159.46x3.97x25.98x-.--% 4.43B
22.39x3.57x11.01x1.8% 4.38B
16.62x - - 3.86% 2.8B
Average 18.53x 6.62x -17.95x 1.42% 6.75B
Weighted average by Cap. -3.45x 9.19x -46.68x 0.89%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA